Medical/Pharmaceuticals
HanchorBio Prices IPO at NT$120 Ahead of Innovation Board Listing on May 29
TAIPEI and SHANGHAI and SAN FRANCISCO, May 26, 2026 /PRNewswire/ -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, today announced the completion of bookbuilding for its initial public of...
2026-05-26 16:00
6564
DOSIsoft Launches DOSIsoft Theranostics, a Dedicated Entity to Accelerate Software Innovation for Personalized Nuclear Medicine and Theranostics
PARIS, May 26, 2026 /PRNewswire/ -- Ahead of SNMMI 2026, DOSIsoft
2026-05-26 15:00
3676
Venus Medtech Hosts Inaugural Global Partner Summit in Paris
Company highlights international growth strategy, expanding structural heart portfolio, and commercialization priorities PARIS, May 26, 2026 /PRNewswire/ -- Venus Medtech convened its inaugural Global Partner Summit in Paris under the theme "Insights, Innovation, Impact," bringing together distr...
2026-05-26 15:00
4806
MatOrtho announces ReCerf® 5A* ODEP rating
LEATHERHEAD, England, May 26, 2026 /PRNewswire/ -- MatOrtho is pleased to
announce that ReCerf® has been awarded a 5A* rating by the Orthopaedic Data
Evaluation Panel (ODEP), representing the highest available rating at the
five-year benchmark for orthopaedic implants.
2026-05-26 15:00
3245
Lundbeck receives marketing authorization for Vyepti® (eptinezumab) in South Korea for the preventive treatment of migraine
* Approval granted by South Korea's Ministry of Food and Drug Safety (MFDS) * Eptinezumab is an anti-calcitonin gene-related peptide (CGRP) monoclonal antibody for the preventive treatment of migraine in adults * Authorization supported by the Phase 3 SUNRISE trial conducted in a predominant...
2026-05-26 14:38
5197
"The Era of Cuffless is Here"… Ring-Type Blood Pressure Monitor 'CART BP pro' Becomes World's First to Be Integrated into Official Hypertension Guidelines
SEOUL, South Korea, May 26, 2026 /PRNewswire/ -- Sky Labs (CEO Jack ByungHwan Lee) announced on the 26th that its ring-type cuffless blood pressure monitor, 'CART BP pro,' has been officially integrated into the'2026 Korean Society of Hypertension Guidelines for the Management of Hypertension (6t...
2026-05-26 14:30
5980
Global Times: How mutual commitment of Xizang and medical aid workers improves local healthcare
BEIJING, May 26, 2026 /PRNewswire/ -- National support for Xizang's development has yielded remarkable achievements. Over the decades, numerous volunteers from across the country have come to Xizang, making indispensable contributions to the autonomous region's growth. Their efforts focus on vari...
2026-05-26 12:59
2948
Over 40 Studies Featuring Akeso's Innovative Oncology Agents to Be Presented at ASCO 2026: Ivonescimab's HARMONi-6 Overall Survival Data Selected for Plenary Session
HONG KONG, May 26, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that more than 40 clinical studies of its oncology portfolio will be presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 – June 2 in Chicago, Illin...
2026-05-26 12:35
7034
WuXi Vaccines' Drug Substance Facility Receives Brazil ANVISA GMP Certification for Dengue Vaccine Manufacturing
SUZHOU, China, May 26, 2026 /PRNewswire/ -- WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced today that its drug substance facility (MFG23) located in Suzhou has received Good Manufacturing Pract...
2026-05-26 12:00
3424
Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC)
* This positive CHMP opinion is based on results from the Phase 3 BREAKWATER trial, which showed that encorafenib in combination with cetuximab andmFOLFOX6 demonstrated a statistically significant improvement in the dual primary endpoints of objective response rate (ORR) and progression-free s...
2026-05-25 21:40
6151
Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
* Data spans seven presentations across both solid tumors and hematologic malignancies, providing updates on the potential benefit these therapies may bring to patients. * Data from the elacestrant plus capivasertib regimen of the ELEVATE study will be presented underscoring its potential i...
2026-05-25 18:56
6838
THE FUTURE OF MEN'S HEALTH IS MEASURABLE: EMAGENE.LIFE AND ADAM HEALTH PARTNER TO ADVANCE PRECISION LONGEVITY AND FUNCTIONAL MEDICINE
Emagene.life integrates advanced biodata intelligence, functional medicine, and Avio Health AI technology through a strategic collaboration with Adam Health to support measurable male vitality and longevity. KUALA LUMPUR, Malaysia, May 25, 2026 /PRNewswire/ -- Men's health is entering a new era ...
2026-05-25 13:36
5152
/C O R R E C T I O N -- Medtronic plc/
In the news release, "Medtronic Singapore partners with Society of Colorectal Surgeons to strengthen surgical training", issued on May 25 2026 by Medtronic over PR Newswire, we are advised by the company that the caption text accompanying the image, should read "From left to right: Sharon Lew (Se...
2026-05-25 12:43
5042
Most Singaporeans know about LPAs, but only 1 in 3 have made one
New research by SMU highlights a gap in preparedness, socioeconomic disparities
and need for stronger public support as Singapore ages
SINGAPORE, May 25, 2026 /PRNewswire/ -- A new study by the Singapore
Management University (SMU)
2026-05-25 09:15
3722
From Pakistan to Shanghai: A CAR-T Journey Fighting Relapsed Lymphoma
SHANGHAI, May 25, 2026 /PRNewswire/ -- A 36-year-old Pakistani patient has achieved encouraging early recovery after receiving personalized CAR-T immunotherapy at Jiahui International Cancer Center in Shanghai, following exhausting standard treatments for aggressive recurrent blood cancer. Muham...
2026-05-25 08:41
2991
Informa Markets Puts Bangkok at the Center of Southeast Asia's Pharma Industry, Uniting 400 Exhibitors, Experts from 70 Countries at CPHI South East Asia
The Region's Premier Pharma Exhibition Returns to Bangkok, Elevating Thailand's Role in the ASEAN Pharmaceutical Supply Chain BANGKOK, May 24, 2026 /PRNewswire/ -- Informa Markets sets to organise CPHI South East Asia from 8–10 July 2026 at Queen Sirikit National Convention Center under the them...
2026-05-24 13:00
5111
Meet Clicklinks: The Innovation Hub for Original Drug Discovery
SHANGHAI, May 23, 2026 /PRNewswire/ -- For many participants in the innovative drug discovery arena, AI-STAL and SAI-DA are already familiar names within the Sanyou Bio ecosystem. AI-STAL is recognized as the "Grand Master Librarian" safeguarding a Super Trillion Antibody Library, while SAI-DA is...
2026-05-23 22:00
5191
79th World Health Assembly adopts resolution on hemophilia and other bleeding disorders
MONTREAL, May 23, 2026 /PRNewswire/ -- On May 22, 2026, the 79th World Health Assembly unanimously adopted a resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders. This is a historic development for our community and will help increase diagno...
2026-05-23 02:00
5175
Texas Cardiac Arrhythmia Institute at St. David's Medical Center to host international conference on complex cardiac arrhythmias
EPLive 2026 is a two-day conference that draws the world's top cardiac electrophysiology experts AUSTIN, Texas, May 22, 2026 /PRNewswire/ -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center will host its eighth international symposium on complex arrhythmias on May 28-2...
2026-05-22 21:08
5854
Gene Solutions Showcases AI-Powered Multi-Omics Liquid Biopsy Innovations at TJCC 2026: Advancing Precision Oncology in Taiwan
Satellite symposium and exhibition engagement highlighted strong physician
interest in MRD, MCED, and evidence-driven adoption of genomic testing.
TAIPEI, May 22, 2026 /PRNewswire/ -- Gene Solutions
2026-05-22 14:45
6894
Week's Top Stories
Most Reposted
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
[Picked up by 309 media titles]
2026-07-30 10:45
J.P. Morgan Private Bank Earns Record 10 Accolades at The Asset Triple A Private Capital Awards 2026
[Picked up by 294 media titles]
2026-07-30 15:00KC Global Media announces new travel series "AXN Ultimate Challenge: Sarawak"
[Picked up by 292 media titles]
2026-07-30 09:12
Articura Launches a New Chapter for Sovereign Healthcare AI in Indonesia
[Picked up by 291 media titles]
2026-07-27 19:02
ADA acquires Algonomy, strengthening its intelligent growth platform for a fully agentic experience
[Picked up by 290 media titles]
2026-07-30 15:30
Most Read
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
2026-07-30 10:45
7706
Articura Launches a New Chapter for Sovereign Healthcare AI in Indonesia
2026-07-27 19:02
6749
KC Global Media announces new travel series "AXN Ultimate Challenge: Sarawak"
2026-07-30 09:12
6482